SBI Healthcare Opportunities Fund holds 38 instruments (95.52% equity), led by Sun Pharmaceutical Industries Limited (11.14%), Divi's Laboratories Limited (7.91%) and Acutaas Chemicals Limited (5.03%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of SBI Healthcare Opportunities Fund, managed by SBI Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 38 instruments with an equity allocation of 95.52%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
SBI Healthcare Opportunities Fund's top 10 holdings account for 51.83% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 90.56% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 3 new positions and exited 0 positions, with Sun Pharmaceutical Industries Limited seeing the largest move (-1.19pp to 11.14%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Healthcare Global Enterprises Limited | 1.27% → 1.7% | ▲ +0.43 |
| Dr. Lal Path Labs Ltd. | 1.47% → 1.62% | ▲ +0.15 |
| Acutaas Chemicals Limited | 4.91% → 5.03% | ▲ +0.12 |
| Stock | Weight | Change |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 12.33% → 11.14% | ▼ -1.19 |
| Max Healthcare Institute Limited | 4.31% → 3.8% | ▼ -0.51 |
| Aurobindo Pharma Limited | 3.9% → 3.42% | ▼ -0.48 |
| Apollo Hospitals Enterprise Limited | 4.91% → 4.45% | ▼ -0.46 |
| Fortis Healthcare Limited | 2.82% → 2.36% | ▼ -0.46 |
| JUPITER LIFE LINE HOSPITALS | 2.55% → 2.16% | ▼ -0.39 |
| Aster DM Healthcare Limited | 3.52% → 3.21% | ▼ -0.31 |
| Biocon Limited | 2.67% → 2.37% | ▼ -0.3 |
| Torrent Pharmaceuticals Limited | 4.72% → 4.42% | ▼ -0.3 |
| Cipla Limited | 4.67% → 4.4% | ▼ -0.27 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: SBI Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.